References
- OngKLCheungBMManYBLauCPLamHSPrevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004Hypertension200749697517159087
- MilaniRVReaching for aggressive blood pressure goals: Role of angiotensin receptor blockade in combination therapyAm J Manag Care2005117 SupplS220S22716180960
- CushamWCFordCECutlerJASuccess and prediction of blood pressure control in diverse North American Settings: the hypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)J Clin Hypertens20024393404
- ManciaGDe BackerGDominiczakACifkovaRFagardRGermanoGGuidelines for the Management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society Hypertension (ESH) and the European Society of Cardiology (ESC)J Hypertens2007251105118717563527
- AllemanYFraileBLambertMBarbierMFerberPIzzoJLJrEfficacy of the combination of amlodipine and valsartan in patients with uncontrolled hypertension with previous monotherapy: The Exforge in previous failure after single therapy (EX-fast) studyJ Clin Hypertens200810185194
- PoolJLGlazerRWeinbergerMAlvaradoMHuangJGraffAComparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 versus monotherapy: a double blind placebo controlled study followed by long-term combination therapy in hypertensive adultsClin Ther200729617317379047
- DeziiCMA retrospective study of persistence with single pill combination therapy vs concurrent two pill therapy in patients with hypertensionManag Caree200099 Suppl26
- Product information. http://www.emea.europea.eu
- Assessment report for Exforge HCT. International non-proprietary name: amlodipine besylate/valsartan/hydrochlorothiazide). http://www.emea.europea.eu
- European Medicines Agency (EMEA)Summary of product characteristics: Exforge® (Amlodipine/Valsartan) filmcoated tabletshttp://www.emea.europea.eu
- EuropeanMedicines Agency (EMEA)Summary of product characteristics: Co-diovan® (Valsartan/Hydrochlorothiazide)http://www.emea.europea.eu
- PloskerGLRobinsonDMAmlodipine/valsartan fixed dose combination in hypertensionDrugs20086837338118257612
- CalhounDALacourciereYChiangTYGlazerRDTriple antihypertensive therapy with amlodipine, valsartan and hydrochlorothiazide: A randomized clinical trialHypertension200954323919470877
- ElijovichFLafferCA role for single pill triple-therapy in hypertensionTher Adv Cardiovasc Dis2009323124019443512
- ManciaGLaurentSAgabiti-RoseiEAmbrosioniEBurnierMCaulfieldMJReappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documentJ Hypertens20092721212157
- NasserSALaiZO’ConnorSLiuXFlacKJMDoes earlier attainment of blood pressure goal translate into fewer cardiovascular eventsCurr Hypertens Rev200810398404
- BlackHRTriple fixed-dose combination therapy: back to the pastHypertension200954192219470871